AArtificial intelligence Read More Students are reconsidering majors, career paths due to AI: CNBC surveySeptember 1, 2026 Like many of her fellow college students, Stephanie Park has kept a close eye on how AI might…
MMedication Read More Paxlovid, long Covid, weed, Trump drug deals: Morning RoundsSeptember 1, 2026 Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.…
MMedication Read More New drug for chronic hives registered in Hong KongSeptember 1, 2026 Patients suffering from chronic hives can enjoy more treatment options, as a new drug targeting the disease has…
MMedication Read More Walmart to Pay $50 Million Over Opioid Prescription CaseSeptember 1, 2026 (Gray News) – Walmart has agreed to pay $50 million to the federal government to resolve allegations that…
MMedication Read More MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balanceSeptember 1, 2026 The Medicines and Healthcare products Regulatory Agency (MHRA) has completed its review of Avacopan Vifor (previously known as…
MMedication Read More Lenacapavir shot offers hope, but access is constrainedSeptember 1, 2026 Lindiwe Mqatazana is not taking any chances with her health, or with that of her unborn child. “There…
MMedication Read More Mayo-founded anaphylaxis kits will accommodate new nasal spraySeptember 1, 2026 With the Nasal Adrenaline spray becoming available today in Ireland, a Mayo man who created an ‘Emergency…
MMedication Read More Arthritis Drug Restores 100% Hair Growth in Alopecia Areata TrialSeptember 1, 2026 Clinical trials of upadacitinib showed up to 23 percent of severe alopecia areata patients achieved complete scalp hair…
MMedication Read More Japan to exempt extra charges on OTC-like drugs from taxSeptember 1, 2026 The health ministry plans not to impose consumption tax on additional out-of-pocket costs for prescription drugs with ingredients…
MMedication Read More Ascension mixed own meds instead of buying pre-filled vialsSeptember 1, 2026 NASHVILLE, Tenn. (WTVF) — Last week we showed you the state’s report into the recent medication mix-up at…
MMedication Read More New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesitySeptember 1, 2026 At Week 52, Taltz and Zepbound maintained or further improved psoriasis or psoriatic arthritis disease activity from Week…
MMedication Read More What You Should Know About Compounded MedicationsSeptember 1, 2026 Though they’ve been around for decades, compounded medications have been getting a lot of attention lately with recent…